Professional transitions are inevitable, and the key is understanding how to mitigate risk when navigating these transitions.
Kelley Detweiler
Advertisement
Kelley Detweiler is a DEA & regulatory compliance expert who provides controlled substance and DEA listed chemical solutions to the veterinary, healthcare, supply chain and pharmaceutical industries operating in the public and private sectors. She is a partner in Simple Solutions For Vets with Peter Weinstein, DVM, MBA, and the coauthor of “Safeguarding Controlled Substances” published by AAHA.
Detweiler has spoken on international platforms including the United Nations and continues to speak and write for various industry associations, organizations and publications. Detweiler serves on the Board of Directors for Backbone Software, a supply chain management company for regulated industries based in Silicon Valley, and the New Jersey Cannabusiness Association providing regulatory guidance and advisement on legislation.
Articles by Kelley Detweiler
The medetomidine threat is serious, and veterinary professionals can help mitigate risk by taking action to keep a problem from arising in their facilities.
As the UK leads the charge on banning xylazine, Peter Weinstein, DVM, MBA, and Kelley Detweiler talk about what's next for the US
Veterinary practices face steep penalties for paperwork errors, making proper recordkeeping on controlled substances a non-negotiable aspect of practice management
How can e-prescribing improve the workflow between veterinarians and pharmacists?
Everything you need to know about ePrescribing and why it just makes sense for veterinary practices
The federal government announced an action plan this week to address illegitimate drug use of this veterinary sedative
Xylazine has quickly moved from a pole position to breaking maiden as a non-human drug leading charge into a new human health crisis.
Permitted for use as a veterinary tranquilizer, the drug is illicitly being consumed by individuals with substance addiction
Advertisement
Latest Updated Articles
Xylazine: What’s Next?July 13th 2023
Advertisement
Advertisement
Trending on dvm360
1
Weekly Vet Report: Can pets spread Cyclospora? Plus, the link between gait and canine cognition
2
US pet insurance enrollment increased 9% in 2025, but more than 95% of cats and dogs remain uninsured
3
The next casualty of the overdose crisis could be wildlife conservation
4
Q&A: SGLT2 inhibitors in feline diabetes and what to know about blood ketones, DKA, diet, and monitoring
5